According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. … [ Get More Details ]
A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.
[ Get More Details ]
According to the Pharmaceutical Research and Manufacturers of America, one of the most promising medicines in development is for glioblastoma. The medicine singles out and latches onto the receptors on… [ Get More Details ]
Following the current path, breast cancer incidence rate will increase by 50.8% between 2003 and 2023. If an alternative path is taken, cases will increase by 32.2% between 2003 and… [ Get More Details ]